Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference

Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission